Minneapolis. Doyle's study concluded that Iowa women living in areas supplied by municipal water systems containing higher concentrations of chloroform were at significant risk for both colon cancer and total combined cancers. Because chloroform concentrations in water tested in the study were rarely elevated beyond 100 ppb, Doyle was unable to quantify risks above that level. Ronald Melnick, a toxicologist with the NIEHS and a critic of the EPA's revised goal, asks, "When there's measurable risk at levels below 100 ppb, how can the EPA justify a goal of 300 ppb?"
The EPA counters that it reviewed both studies, along with many others, but remains unconvinced. "We did review the epidemiology data," says Wiltse, "but none of the analyses were more than suggestive, although there were some odds ratios that were greater than one." Moreover, she adds, "The studies were of disinfected water, which contains hundreds of chemicals, not chloroform alone. Chloroform was simply measured in the Doyle study as an indicator of disinfection." In the 31 March 1998 Notice of Data Availability, the EPA pointed out that some positive associations were beset by confounding variables such as smoking, and that results often conflicted with respect to specific sources of exposure. Furthermore, the EPA disagreed with the approach used by Morris, which produced only single numerical estimates of risk, and instead used a set of the most appropriate studies to conduct a distributional "population attributable risk" (PAR) analysis that predicted that between 1,100 and 9,300 cases of bladder cancer might be associated with DBPs annuially. PAR methodology, which presents a range of potential risks to populations rather than a single estimate, is often used by epidemiologists to provide a perspective on the potential magnitude of risks associated with various exposures. Critics of the PAR approach point to the conspictiotis absence of any end points other than bladder cancer and add that despite the EPA's dismissal of the Morris data, its estimated range for annual bladder cancers captured the Morris study point estimate of 4,300 cases and its upper bound estimate of 9,000 approached the Morris estimate for all cancers combined. In other words, regardless of the differences in methodology, both studies arrived at essentially the same numerical estimate of the risk of bladder cancer from exposure to DBPs in drinking water. "So why all the sound and fury about the Morris study being unreliable?" asks Erik Olson, a senior attorney with the Natural Resources Defense Coouncil.
Focus on Animal Studies
Proponents of a revised MCLG say the epidemiological associations should be viewed in light of toxicological evidence suggesting that cancer can be induced only with extremely high exposures that are often cytotoxic in target organs. Studies in several species of mice and rats support this view. In most cases, only concentrated, repeated doses, such as those produced by gavage, have proven effective. However, critics remain skeptical and suggest that chloroform carcinogenicity at doses below those causing cytotoxicity and regenerative cell proliferation isn't well characterized. Melnick, in particular, has found that low-dose exposures to brominated THMs including BDCM and DBCM can produce liver tumors in female mice with no effect on liver toxicity or hepatocyte proliferation. Whether chloroform is similarly capable, he says, is not George 1ticier, director of the Environmental Toxicology Progranm at the NIEHS, says there's no doubt that the EPA will adopt a nonlinear approach for somile carcinogens as it works its way througlh the 1996 cancer guidelines, which will likely be finalized this fall. "They may Ultirnately adopt such an approach for chloroform," he says. But Lucier concedes that chloroform studies have yielded some ambiguous data. "I think it was a close call," he says. "I can see how people would differ on which approach to use."
In any event, the whole issue is still an open book, and the value that the chloroform MCLG will ultimately be assigned remains to be seen. According to Wiltse, the original proposal of 300 ppb has already been abandoned as the EPA has begun considering additional source contributions for chloroform that include inhalational and dermal exposures. Incorporating these pathways into the risk equation has yielded revised estimates for the MC,G of between 60 and 70 ppb. Says Lucier. "This is a prototypical issue, more a matter of principle than of safe exposuLc levels. Industrv would like to see the FPA implement the revised guidelines. It wouldn't take much more evidence to support a nonlinear approach for chloroform." Charles W. Schmidt Volume 107, Number 7 July 1999 * Environmental Health Perspeptiv_i
